SNWV

#4336
SANUWAVE Health, Inc. - Common Stock
4.6 0 USD
-0.02%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
4.60
4.60
Intervallo Annuale
4.50
25.62
Variazione giornaliera
-1.92%
Variazione Mensile
-25.45%
Variazione di 6 mesi
-80.19%
Variazione Annuale
-80.97%
Chiusura Precedente
4.6 9
Open
4.6 0
Minimo
4.6 0
Massimo
4.6 0
Volume
4
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
SANUWAVE Health, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
SANUWAVE Health, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K

SANUWAVE Health, Inc. current report, Q3 FY2026

Full document

Business Context and Reporting Period

Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 13, 2026
Reporting Period: Quarter ended June 30, 2026
Context: The Company issued a press release announcing preliminary financial results for the quarter ended June 30, 2026. The full details of these results are contained in Exhibit 99.1 (Press Release) attached to this filing.

Key Financial Metrics

The provided text for this Form 8-K serves as a notification of the release of preliminary results and does not contain specific numerical data. Consequently, the following metrics are not available in the source text:

  • Revenue: Not provided in filing text.
  • Profit/Loss: Not provided in filing text.
  • Cash Flow: Not provided in filing text.
  • Margins: Not provided in filing text.
  • Debt and Liquidity: Not provided in filing text.

Material Changes

The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for specific year-over-year or quarter-over-quarter performance analysis.

Guidance, Outlook, and Risks

Management Commentary: The filing confirms the issuance of a press release regarding preliminary results but does not include specific management commentary, forward-looking guidance, or outlook statements within the body of the 8-K text.
Risks and Contingencies: No specific risks, contingencies, or unusual items are detailed in the provided text. The filing includes standard disclaimers that the information furnished in Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release dated July 13, 2026) to obtain the actual preliminary financial figures for the quarter ended June 30, 2026.
  • Verify the specific trading symbol SNWV on The Nasdaq Stock Market LLC for current market reaction to the preliminary results.
  • Confirm whether the preliminary results include any restatements or adjustments to prior periods, as this is not detailed in the 8-K summary text.
  • Check for subsequent filings (e.g., Form 10-Q) that will provide audited or reviewed financial statements to validate the preliminary numbers.